Cyclopharm Limited to welcome Mr. John Wigglesworth to its Board as a Non- Executive Director. Mr. Wigglesworth brings with him 37 years of professional experience, including nearly 25 years as a Partner at KPMG. His diverse background as a Chartered Accountant and Company Director, coupled with his extensive industry experience, positions him as a valuable addition to Cyclopharm's Board of Directors.

Mr. Wigglesworth's career highlights include: Experienced company director having held several previous Board positions over the past decade including Atlas Arteria Limited and also in public sector health entities. While at KPMG John advised and supported many leading Australian and international multi- national companies during periods of international growth. Held various KPMG leadership positions including serving as a member of the Audit Leadership Group and National leader of KPMG Audit's Retention & Conversion function, managing proposals, client relationship management, and global management groups/committees.

Expertise in ASX listing readiness, IPOs, and business transition, working closely with companies navigating the challenges of transitioning to a listed entity. Financial reporting and market communications specialist, with a focus on ASX and regulatory reporting along with broader financial reporting matters. Strong background in internal control and accounting processes, including applying Lean principles and advising on system design.

Extensive experience in risk management, including Cyber, and serving as Chairman of the Audit & Risk Committee at both Atlas Arteria Limited and Macquarie University.